August 1, 2014

Senior Consultant Jill E. Sackman, D.V.M., Ph.D., and Research Analyst Michael Kuchenreuther, Ph.D., discuss the importance of coupling big data with personalized medicine as a tool for pharma manufacturers to transform the way biopharmaceutical drugs are discovered, developed and marketed.

Jill and Michael provide insight on data analytic strategies that pharmaceutical companies are considering to capitalize on opportunities of personalized medicine in Marrying Big Data with Personalized Medicine, published August 2014, by BioPharm International.